Search company, investor...


Series B | Alive

Total Raised


Last Raised

$8.6M | 24 yrs ago

About Camitro

Developer of technology to help predict the pharmacokinetic properties of drugs. The company was acquired by ArQule (Nasdaq: ARQL).

Headquarters Location

Chesterford Research Park Saffron Walden

CB10 1XL,

United Kingdom



Camitro Frequently Asked Questions (FAQ)

  • What is Camitro's latest funding round?

    Camitro's latest funding round is Series B.

  • How much did Camitro raise?

    Camitro raised a total of $9.6M.

  • Who are the investors of Camitro?

    Investors of Camitro include Abingworth and Alloy Ventures.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.